probenecid has been researched along with Heart Disease, Ischemic in 2 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Onódi, Z | 2 |
| Koch, S | 2 |
| Rubinstein, J | 3 |
| Ferdinandy, P | 2 |
| Varga, ZV | 2 |
| Koch, SE | 1 |
| Tranter, M | 1 |
| Robbins, N | 1 |
| Luther, K | 1 |
| Singh, U | 1 |
| Jiang, M | 1 |
| Ren, X | 1 |
| Tee, T | 1 |
| Smith, L | 1 |
| Varma, P | 1 |
| Jones, WK | 1 |
1 review available for probenecid and Heart Disease, Ischemic
| Article | Year |
|---|---|
Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Drug Repositioning; Heart Failure; Humans; Myocard | 2023 |
Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Drug Repositioning; Heart Failure; Humans; Myocard | 2023 |
Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Drug Repositioning; Heart Failure; Humans; Myocard | 2023 |
Drug repurposing for cardiovascular diseases: New targets and indications for probenecid.
Topics: Cardiovascular Diseases; Coronary Artery Disease; Drug Repositioning; Heart Failure; Humans; Myocard | 2023 |
1 other study available for probenecid and Heart Disease, Ischemic
| Article | Year |
|---|---|
Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.
Topics: Administration, Oral; Animals; Calcium Signaling; Cardiotonic Agents; Cell Line; Cell Survival; Dise | 2013 |